Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 459 articles:
HTML format
Text format



Single Articles


    January 2017
  1. LIU S, Zhao K, Su X, Lu L, et al
    MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.
    PLoS One. 2017;12:e0169701.
    PubMed     Text format     Abstract available


  2. ASSELAH T, Moreno C, Sarrazin C, Gschwantler M, et al
    Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
    PLoS One. 2017;12:e0168713.
    PubMed     Text format     Abstract available


  3. ZHU Z, Tran H, Mathahs MM, Moninger TO, et al
    HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
    PLoS One. 2017;12:e0166853.
    PubMed     Text format     Abstract available


  4. WANG SC, Lai KR, Li CY, Chiang CS, et al
    The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities.
    PLoS One. 2017;12:e0164281.
    PubMed     Text format     Abstract available


  5. STAHMEYER JT, Rossol S, Liersch S, Guerra I, et al
    Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany.
    PLoS One. 2017;12:e0169401.
    PubMed     Text format     Abstract available


  6. HOSSAIN MG, Ueda K
    Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.
    PLoS One. 2017;12:e0167871.
    PubMed     Text format     Abstract available


  7. PUGA MA, Bandeira LM, Pompilio MA, Croda J, et al
    Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil.
    PLoS One. 2017;12:e0169195.
    PubMed     Text format     Abstract available


  8. KIM DY, Han KH, Jun B, Kim TH, et al
    Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.
    PLoS One. 2017;12:e0167770.
    PubMed     Text format     Abstract available


  9. WANG J, Su C, Liu R, Liu B, et al
    A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine.
    PLoS One. 2017;12:e0170313.
    PubMed     Text format     Abstract available


  10. HU J, Gu X, Tao X, Qian Y, et al
    Prevalence and Trends of HIV, Syphilis, and HCV in Migrant and Resident Men Who Have Sex with Men in Shandong, China: Results from a Serial Cross-Sectional Study.
    PLoS One. 2017;12:e0170443.
    PubMed     Text format     Abstract available


  11. KIM KA, Lee A, Ki M, Jeong SH, et al
    Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.
    PLoS One. 2017;12:e0170432.
    PubMed     Text format     Abstract available


  12. NAM JY, Lee JH, Kim HY, Kim JE, et al
    Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.
    PLoS One. 2017;12:e0166188.
    PubMed     Text format     Abstract available


  13. WU Q, An J, She R, Shi R, et al
    Detection of Genotype 4 Swine Hepatitis E Virus in Systemic Tissues in Cross-Species Infected Rabbits.
    PLoS One. 2017;12:e0171277.
    PubMed     Text format     Abstract available


  14. DEGRE D, Serste T, Lasser L, Delwaide J, et al
    Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
    PLoS One. 2017;12:e0170933.
    PubMed     Text format     Abstract available


  15. APPELMAN MD, Chakraborty A, Protzer U, McKeating JA, et al
    N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection.
    PLoS One. 2017;12:e0170419.
    PubMed     Text format     Abstract available


  16. INOUE T, Hmwe SS, Shimada N, Kato K, et al
    Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
    PLoS One. 2017;12:e0170667.
    PubMed     Text format     Abstract available


  17. AHN HJ, Song MJ, Jang JW, Bae SH, et al
    Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.
    PLoS One. 2017;12:e0170362.
    PubMed     Text format     Abstract available


  18. ZHAI N, Li H, Song H, Yang Y, et al
    Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
    PLoS One. 2017;12:e0170516.
    PubMed     Text format     Abstract available


  19. GAMBATO M, Caro-Perez N, Gonzalez P, Canete N, et al
    Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
    PLoS One. 2017;12:e0170913.
    PubMed     Text format     Abstract available


  20. TSUTSUMI T, Okushin K, Enooku K, Fujinaga H, et al
    Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver.
    PLoS One. 2017;12:e0170461.
    PubMed     Text format     Abstract available


  21. NIEN HC, Hsu SJ, Su TH, Yang PJ, et al
    High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
    PLoS One. 2017;12:e0170028.
    PubMed     Text format     Abstract available


  22. XING T, Xu H, Cao L, Ye M, et al
    HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.
    PLoS One. 2017;12:e0169444.
    PubMed     Text format     Abstract available


  23. CASCIANO JC, Duchemin NJ, Lamontagne RJ, Steel LF, et al
    Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes.
    PLoS One. 2017;12:e0168328.
    PubMed     Text format     Abstract available


  24. WU B, Xiao F, Li P, Du Y, et al
    Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR.
    PLoS One. 2017;12:e0170290.
    PubMed     Text format     Abstract available


  25. ZHANG C, Hua R, Cui Y, Wang S, et al
    Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
    PLoS One. 2017;12:e0171217.
    PubMed     Text format     Abstract available


  26. WELSCH C, Efinger M, von Wagner M, Herrmann E, et al
    Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.
    PLoS One. 2017;12:e0171755.
    PubMed     Text format     Abstract available


  27. RUIZ-EXTREMERA A, Pavon-Castillero EJ, Florido M, Munoz de Rueda P, et al
    Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children.
    PLoS One. 2017;12:e0172527.
    PubMed     Text format     Abstract available


  28. MIYAKI E, Hiraga N, Imamura M, Uchida T, et al
    Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus.
    PLoS One. 2017;12:e0172412.
    PubMed     Text format     Abstract available


  29. KONDILI LA, Gaeta GB, Ieluzzi D, Zignego AL, et al
    Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    PLoS One. 2017;12:e0172159.
    PubMed     Text format     Abstract available


  30. LIN SY, Lin CL, Ju SW, Wang IK, et al
    Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.
    PLoS One. 2017;12:e0173125.
    PubMed     Text format     Abstract available


  31. THANAPIROM K, Suksawatamnuay S, Sukeepaisarnjareon W, Tanwandee T, et al
    Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study.
    PLoS One. 2017;12:e0173263.
    PubMed     Text format     Abstract available


  32. COUTO I, Victoria M, Veloso VG, Rodrigues L, et al
    Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.
    PLoS One. 2017;12:e0174453.
    PubMed     Text format     Abstract available


  33. GARDINALI NR, Guimaraes JR, Melgaco JG, Kevorkian YB, et al
    Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    PLoS One. 2017;12:e0174070.
    PubMed     Text format     Abstract available


  34. YOSHIOKA T, Tatsumi T, Miyagi T, Mukai K, et al
    Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    PLoS One. 2017;12:e0174103.
    PubMed     Text format     Abstract available


  35. RALLON N, Garcia M, Garcia-Samaniego J, Rodriguez N, et al
    HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    PLoS One. 2017;12:e0173943.
    PubMed     Text format     Abstract available


  36. GUPTA N, Kabahizi J, Mukabatsinda C, Walker TD, et al
    "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
    PLoS One. 2017;12:e0174148.
    PubMed     Text format     Abstract available


    January 2016
  37. GONZALEZ-ALDACO K, Rebello Pinho JR, Roman S, Gleyzer K, et al
    Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico.
    PLoS One. 2016;11:e0146258.
    PubMed     Text format     Abstract available


  38. HANDISURYA A, Kerscher C, Tura A, Herkner H, et al
    Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    PLoS One. 2016;11:e0145319.
    PubMed     Text format     Abstract available


  39. BRANCHE E, Conzelmann S, Parisot C, Bedert L, et al
    Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.
    PLoS One. 2016;11:e0146000.
    PubMed     Text format     Abstract available


  40. SASAKI R, Kanda T, Nakamura M, Nakamoto S, et al
    Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells.
    PLoS One. 2016;11:e0146314.
    PubMed     Text format     Abstract available


  41. ULITZKY L, Lafer MM, KuKuruga MA, Silberstein E, et al
    A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
    PLoS One. 2016;11:e0145212.
    PubMed     Text format     Abstract available


  42. DU H, Zhang S, Song M, Wang Y, et al
    Assessment of a Flavone-Polysaccharide Based Prescription for Treating Duck Virus Hepatitis.
    PLoS One. 2016;11:e0146046.
    PubMed     Text format     Abstract available


  43. CHEN QW, Li HJ, Chen YN, Ning ZY, et al
    Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0139782.
    PubMed     Text format     Abstract available


  44. KONGKAVITOON P, Tangkijvanich P, Hirankarn N, Palaga T, et al
    Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0146696.
    PubMed     Text format     Abstract available


  45. CHEN R, Kobewka M, Addison W, Lachance G, et al
    Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.
    PLoS One. 2016;11:e0147007.
    PubMed     Text format     Abstract available


  46. BIVIGOU-MBOUMBA B, Francois-Souquiere S, Deleplancque L, Sica J, et al
    Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    PLoS One. 2016;11:e0143869.
    PubMed     Text format     Abstract available


  47. WEDEMEYER H, Forns X, Hezode C, Lee SS, et al
    Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.
    PLoS One. 2016;11:e0145409.
    PubMed     Text format     Abstract available


  48. MOON JS, Lee SH, Kim EJ, Cho H, et al
    Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    PLoS One. 2016;11:e0146710.
    PubMed     Text format     Abstract available


  49. SINGH S, Vedi S, Samrat SK, Li W, et al
    Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
    PLoS One. 2016;11:e0146404.
    PubMed     Text format     Abstract available


  50. LIU Y, Zhang L, Zhou JY, Pan J, et al
    Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.
    PLoS One. 2016;11:e0146980.
    PubMed     Text format     Abstract available


  51. LITTERA R, Chessa L, Onali S, Figorilli F, et al
    Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    PLoS One. 2016;11:e0146086.
    PubMed     Text format     Abstract available


  52. JIANG L, Wu X, He F, Liu Y, et al
    Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog.
    PLoS One. 2016;11:e0147440.
    PubMed     Text format     Abstract available


  53. GUPTA G, Song J
    C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication Complex.
    PLoS One. 2016;11:e0147278.
    PubMed     Text format     Abstract available


  54. KILPATRICK S, Dreistadt M, Frowde P, Powell R, et al
    Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.
    PLoS One. 2016;11:e0146560.
    PubMed     Text format     Abstract available


  55. ZHAO Q, Wen Y, Jiang Y, Zhang C, et al
    Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment.
    PLoS One. 2016;11:e0147566.
    PubMed     Text format     Abstract available


  56. LIU S, Zhao T, Song B, Zhou J, et al
    Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells.
    PLoS One. 2016;11:e0147991.
    PubMed     Text format     Abstract available


  57. ALDAMIZ-ECHEVARRIA T, Berenguer J, Miralles P, Jimenez-Sousa MA, et al
    Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.
    PLoS One. 2016;11:e0148537.
    PubMed     Text format     Abstract available


  58. NEUKAM K, Mira JA, Collado A, Rivero-Juarez A, et al
    Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.
    PLoS One. 2016;11:e0148104.
    PubMed     Text format     Abstract available


  59. WEI Y, Li J, Qing J, Huang M, et al
    Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    PLoS One. 2016;11:e0148181.
    PubMed     Text format     Abstract available


  60. THOLEN AT, Schinkel J, Molenkamp R, Ang CW, et al
    Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands.
    PLoS One. 2016;11:e0146906.
    PubMed     Text format     Abstract available


  61. STINDT S, Cebula P, Albrecht U, Keitel V, et al
    Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    PLoS One. 2016;11:e0148711.
    PubMed     Text format     Abstract available


  62. RENDON J, Hoyos MC, di Filippo D, Cortes-Mancera F, et al
    Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis.
    PLoS One. 2016;11:e0148417.
    PubMed     Text format     Abstract available


  63. WASITTHANKASEM R, Posuwan N, Vichaiwattana P, Theamboonlers A, et al
    Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
    PLoS One. 2016;11:e0149362.
    PubMed     Text format     Abstract available


  64. IZQUIERDO L, Oliveira C, Fournier C, Descamps V, et al
    Hepatitis C Virus Resistance to Carbohydrate-Binding Agents.
    PLoS One. 2016;11:e0149064.
    PubMed     Text format     Abstract available


  65. BRUNI R, Taffon S, Equestre M, Chionne P, et al
    Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013.
    PLoS One. 2016;11:e0149642.
    PubMed     Text format     Abstract available


  66. HUNG IF, Wong DK, Poon RT, Fong DY, et al
    Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0148493.
    PubMed     Text format     Abstract available


  67. ROGAL SS, Arnold RM, Chapko M, Hanusa BV, et al
    The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.
    PLoS One. 2016;11:e0148596.
    PubMed     Text format     Abstract available


  68. CHAABNA K, Kouyoumjian SP, Abu-Raddad LJ
    Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0149966.
    PubMed     Text format     Abstract available


  69. XIE B, Zhang P, Liu M, Zeng W, et al
    Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China.
    PLoS One. 2016;11:e0149199.
    PubMed     Text format     Abstract available


  70. CARABALLO CORTES K, Zagordi O, Jablonska J, Pawelczyk A, et al
    Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing.
    PLoS One. 2016;11:e0150311.
    PubMed     Text format     Abstract available


  71. WANG C, Shi CX, Rou K, Zhao Y, et al
    Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.
    PLoS One. 2016;11:e0147922.
    PubMed     Text format     Abstract available


  72. WU CK, Chang KC, Tseng PL, Lu SN, et al
    Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels.
    PLoS One. 2016;11:e0142378.
    PubMed     Text format     Abstract available


  73. O'CONNELL S, Lillis D, Cotter A, O'Dea S, et al
    Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.
    PLoS One. 2016;11:e0150546.
    PubMed     Text format     Abstract available


  74. BEAUMONT E, Roch E, Chopin L, Roingeard P, et al
    Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties.
    PLoS One. 2016;11:e0151626.
    PubMed     Text format     Abstract available


  75. TSAI MC, Chen CH, Tseng PL, Hung CH, et al
    Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study.
    PLoS One. 2016;11:e0149761.
    PubMed     Text format     Abstract available


  76. JANJUA NZ, Kuo M, Chong M, Yu A, et al
    Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
    PLoS One. 2016;11:e0150176.
    PubMed     Text format     Abstract available


  77. REN JH, Chen X, Zhou L, Tao NN, et al
    Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression.
    PLoS One. 2016;11:e0150961.
    PubMed     Text format     Abstract available


  78. YAO M, Lu X, Lei Y, Yang J, et al
    Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease Activity.
    PLoS One. 2016;11:e0150894.
    PubMed     Text format     Abstract available


  79. ZHUANG Y, Li Y, Li X, Xie Q, et al
    Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis through an ROS-Mediated p38/MAPK Pathway.
    PLoS One. 2016;11:e0149754.
    PubMed     Text format     Abstract available


  80. POSUWAN N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, et al
    The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    PLoS One. 2016;11:e0150499.
    PubMed     Text format     Abstract available


  81. SPINDELBOECK W, Horvath A, Tawdrous M, Schmerbock B, et al
    Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.
    PLoS One. 2016;11:e0150299.
    PubMed     Text format     Abstract available


  82. CHEN M, Wong WW, Law MG, Kiertiburanakul S, et al
    Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    PLoS One. 2016;11:e0150512.
    PubMed     Text format     Abstract available


  83. ASSELAH T, Thompson AJ, Flisiak R, Romero-Gomez M, et al
    A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.
    PLoS One. 2016;11:e0150569.
    PubMed     Text format     Abstract available


  84. MATSUMOTO N, Ikeda H, Shigefuku R, Hattori N, et al
    Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.
    PLoS One. 2016;11:e0151238.
    PubMed     Text format     Abstract available


  85. DIETZE KK, Schimmer S, Kretzmer F, Wang J, et al
    Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model.
    PLoS One. 2016;11:e0151717.
    PubMed     Text format     Abstract available


  86. SA-NGUANMOO P, Posuwan N, Vichaiwattana P, Vuthitanachot V, et al
    Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand.
    PLoS One. 2016;11:e0151304.
    PubMed     Text format     Abstract available


  87. TAWARA S, Tatsumi T, Iio S, Kobayashi I, et al
    Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    PLoS One. 2016;11:e0151828.
    PubMed     Text format     Abstract available


  88. WANDELER G, Musukuma K, Zurcher S, Vinikoor MJ, et al
    Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
    PLoS One. 2016;11:e0152043.
    PubMed     Text format     Abstract available


  89. BAGHERI AMIRI F, Mostafavi E, Mirzazadeh A
    HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0151946.
    PubMed     Text format     Abstract available


  90. CHEN Y, Zhao Q, Liu B, Wang L, et al
    A Novel Blocking ELISA for Detection of Antibodies against Hepatitis E Virus in Domestic Pigs.
    PLoS One. 2016;11:e0152639.
    PubMed     Text format     Abstract available


  91. YU JS, Chen WC, Tseng CK, Lin CK, et al
    Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.
    PLoS One. 2016;11:e0152236.
    PubMed     Text format     Abstract available


  92. REN S, Wang J, Chen TL, Li HY, et al
    Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms.
    PLoS One. 2016;11:e0152721.
    PubMed     Text format     Abstract available


  93. FOSTER GR, Coppola C, Derbala M, Ferenci P, et al
    Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
    PLoS One. 2016;11:e0151703.
    PubMed     Text format     Abstract available


  94. ZHANG X, Bilic I, Marek A, Glosmann M, et al
    C-Terminal Amino Acids 471-507 of Avian Hepatitis E Virus Capsid Protein Are Crucial for Binding to Avian and Human Cells.
    PLoS One. 2016;11:e0153723.
    PubMed     Text format     Abstract available


  95. JI J, Wang H, Li Y, Zheng L, et al
    Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus alpha-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    PLoS One. 2016;11:e0153227.
    PubMed     Text format     Abstract available


  96. SAID EA, Al-Reesi I, Al-Riyami M, Al-Naamani K, et al
    A Potential Inhibitory Profile of Liver CD68+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression.
    PLoS One. 2016;11:e0153191.
    PubMed     Text format     Abstract available


  97. RIZK HH, Hamdy NM, Al-Ansari NL, El-Mesallamy HO, et al
    Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.
    PLoS One. 2016;11:e0153895.
    PubMed     Text format     Abstract available


  98. RAJHI M, Ghedira K, Chouikha A, Djebbi A, et al
    Phylogenetic Analysis and Epidemic History of Hepatitis C Virus Genotype 2 in Tunisia, North Africa.
    PLoS One. 2016;11:e0153761.
    PubMed     Text format     Abstract available


  99. CHUECA N, Rivadulla I, Lovatti R, Reina G, et al
    Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.
    PLoS One. 2016;11:e0153754.
    PubMed     Text format     Abstract available


  100. WANG Z, Chen Y, Xie S, Lv H, et al
    Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    PLoS One. 2016;11:e0153804.
    PubMed     Text format     Abstract available


  101. MACPARLAND SA, Fadel SM, Mihajlovic V, Fawaz A, et al
    HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    PLoS One. 2016;11:e0154433.
    PubMed     Text format     Abstract available


  102. GAO Y, Ren H, Meng F, Li J, et al
    Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    PLoS One. 2016;11:e0154419.
    PubMed     Text format     Abstract available


  103. RAMANATHAN A, Gusarova V, Stahl N, Gurnett-Bander A, et al
    Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
    PLoS One. 2016;11:e0154498.
    PubMed     Text format     Abstract available


  104. HAN Y, Niu J, Wang D, Li Y, et al
    Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0153882.
    PubMed     Text format     Abstract available


  105. GALLAY PA, Chatterji U, Bobardt MD, Long Z, et al
    Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175.
    PLoS One. 2016;11:e0152036.
    PubMed     Text format     Abstract available


  106. NGUYEN TRUONG T, Laureillard D, Lacombe K, Duong Thi H, et al
    High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    PLoS One. 2016;11:e0153744.
    PubMed     Text format     Abstract available


  107. IBRAHIM MK, Salum GM, Bader El Din NG, Dawood RM, et al
    Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.
    PLoS One. 2016;11:e0154512.
    PubMed     Text format     Abstract available


  108. KUO YH, Tsai MC, Kee KM, Chang KC, et al
    Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.
    PLoS One. 2016;11:e0155544.
    PubMed     Text format     Abstract available


  109. WANG D, Chen TW, Zhang XM, Li J, et al
    Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis.
    PLoS One. 2016;11:e0154545.
    PubMed     Text format     Abstract available


  110. WALDENSTROM J, Westin J, Nystrom K, Christensen P, et al
    Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection.
    PLoS One. 2016;11:e0155142.
    PubMed     Text format     Abstract available


  111. GRANADOS-GARCIA V, Contreras AM, Garcia-Pena C, Salinas-Escudero G, et al
    Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors.
    PLoS One. 2016;11:e0154625.
    PubMed     Text format     Abstract available


  112. EMBADE N, Marino Z, Diercks T, Cano A, et al
    Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.
    PLoS One. 2016;11:e0155094.
    PubMed     Text format     Abstract available


  113. KALAGHATGI P, Sikorski AM, Knops E, Rupp D, et al
    Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.
    PLoS One. 2016;11:e0155869.
    PubMed     Text format     Abstract available


  114. NEUKAM K, Espinosa N, Collado A, Delgado-Fernandez M, et al
    Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study.
    PLoS One. 2016;11:e0155842.
    PubMed     Text format     Abstract available


  115. WASITTHANKASEM R, Posuwan N, Vichaiwattana P, Theamboonlers A, et al
    Correction: Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
    PLoS One. 2016;11:e0152451.
    PubMed     Text format     Abstract available


  116. CHEN J, Liu Y, Zhao J, Xu Z, et al
    Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
    PLoS One. 2016;11:e0155654.
    PubMed     Text format     Abstract available


  117. YANG L, Yang X, Kong X, Cao Z, et al
    Covariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B.
    PLoS One. 2016;11:e0156166.
    PubMed     Text format     Abstract available


  118. BERTISCH B, Giudici F, Negro F, Moradpour D, et al
    Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations.
    PLoS One. 2016;11:e0155464.
    PubMed     Text format     Abstract available


  119. STONE J, Martin NK, Hickman M, Hellard M, et al
    The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
    PLoS One. 2016;11:e0156213.
    PubMed     Text format     Abstract available


  120. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.
    PLoS One. 2016;11:e0156604.
    PubMed     Text format     Abstract available


  121. DIETZ J, Rupp D, Susser S, Vermehren J, et al
    Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.
    PLoS One. 2016;11:e0156731.
    PubMed     Text format     Abstract available


  122. ASPORD C, Bruder Costa J, Jacob MC, Dufeu-Duchesne T, et al
    Remodeling of B-Cell Subsets in Blood during Pegylated IFNalpha-2a Therapy in Patients with Chronic Hepatitis B Infection.
    PLoS One. 2016;11:e0156200.
    PubMed     Text format     Abstract available


  123. KLUSHKINA VV, Kyuregyan KK, Kozhanova TV, Popova OE, et al
    Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia.
    PLoS One. 2016;11:e0157161.
    PubMed     Text format     Abstract available


  124. SILBERSTEIN E, Ulitzky L, Lima LA, Cehan N, et al
    HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis.
    PLoS One. 2016;11:e0155708.
    PubMed     Text format     Abstract available


  125. LIN SY, Toyoda H, Kumada T, Liu HF, et al
    Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan.
    PLoS One. 2016;11:e0157103.
    PubMed     Text format     Abstract available


  126. NARAYANAN S, Nieh AH, Kenwood BM, Davis CA, et al
    Distinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0156996.
    PubMed     Text format     Abstract available


  127. CHEN GF, Wei L, Chen J, Duan ZP, et al
    Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
    PLoS One. 2016;11:e0155934.
    PubMed     Text format     Abstract available


  128. CHIU KW, Nakano T, Chen KD, Lin CC, et al
    Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.
    PLoS One. 2016;11:e0156846.
    PubMed     Text format     Abstract available


  129. AMPAH KA, Pinho-Nascimento CA, Kerber S, Asare P, et al
    Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana.
    PLoS One. 2016;11:e0156864.
    PubMed     Text format     Abstract available


  130. WEI W, Jiang J, Liang H, Gao L, et al
    Application of a Combined Model with Autoregressive Integrated Moving Average (ARIMA) and Generalized Regression Neural Network (GRNN) in Forecasting Hepatitis Incidence in Heng County, China.
    PLoS One. 2016;11:e0156768.
    PubMed     Text format     Abstract available


  131. CANIONI D, Michot JM, Rabiega P, Molina TJ, et al
    In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
    PLoS One. 2016;11:e0156384.
    PubMed     Text format     Abstract available


  132. AL-MAHTAB M, Bazinet M, Vaillant A
    Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.
    PLoS One. 2016;11:e0156667.
    PubMed     Text format     Abstract available


  133. LUO X, Huang Y, Chen Y, Tu Z, et al
    Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0157708.
    PubMed     Text format     Abstract available


  134. VERNAZ N, Girardin F, Goossens N, Brugger U, et al
    Drug Pricing Evolution in Hepatitis C.
    PLoS One. 2016;11:e0157098.
    PubMed     Text format     Abstract available


  135. HUIK K, Avi R, Pauskar M, Kallas E, et al
    A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.
    PLoS One. 2016;11:e0156850.
    PubMed     Text format     Abstract available


  136. D'AMBROSIO R, Degasperi E, Aghemo A, Fraquelli M, et al
    Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.
    PLoS One. 2016;11:e0155967.
    PubMed     Text format     Abstract available


  137. KIM YI, Kim HS, Park JW
    Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
    PLoS One. 2016;11:e0157299.
    PubMed     Text format     Abstract available


  138. ROUX P, Rojas Castro D, Ndiaye K, Debrus M, et al
    Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study.
    PLoS One. 2016;11:e0157062.
    PubMed     Text format     Abstract available


  139. BURKE SCHINKEL SC, Carrasco-Medina L, Cooper CL, Crawley AM, et al
    Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0157055.
    PubMed     Text format     Abstract available


  140. DOYLE JS, Grebely J, Spelman T, Alavi M, et al
    Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
    PLoS One. 2016;11:e0150655.
    PubMed     Text format     Abstract available


  141. ZHOU K, Liang Z, Wang C, Hu F, et al
    Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naive HIV/HCV Co-Infected Patients in China.
    PLoS One. 2016;11:e0157438.
    PubMed     Text format     Abstract available


  142. KUNTZEN T, Kuhn S, Kuntzen D, Seifert B, et al
    Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0158512.
    PubMed     Text format     Abstract available


  143. HUANG L, Liu C, Deng Y, Liu Y, et al
    Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study.
    PLoS One. 2016;11:e0158241.
    PubMed     Text format     Abstract available


  144. GLAVIND E, Aagaard NK, Gronbaek H, Moller HJ, et al
    Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis.
    PLoS One. 2016;11:e0158388.
    PubMed     Text format     Abstract available


  145. HOMS M, Rodriguez-Frias F, Gregori J, Ruiz A, et al
    Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection.
    PLoS One. 2016;11:e0158557.
    PubMed     Text format     Abstract available


  146. SHI L, Qin E, Zhou J, Zhao J, et al
    HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.
    PLoS One. 2016;11:e0158386.
    PubMed     Text format     Abstract available


  147. MLUNDE LB, Sunguya BF, Mbwambo JK, Ubuguyu OS, et al
    A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania.
    PLoS One. 2016;11:e0148598.
    PubMed     Text format     Abstract available


  148. MUNYUA PM, Murithi RM, Ithondeka P, Hightower A, et al
    Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya.
    PLoS One. 2016;11:e0144570.
    PubMed     Text format     Abstract available


  149. MAEDA Y, Migita K, Higuchi O, Mukaino A, et al
    Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
    PLoS One. 2016;11:e0146048.
    PubMed     Text format     Abstract available


  150. MAOR Y, Malnick SD, Melzer E, Leshno M, et al
    Treatment of Chronic Hepatitis C in the Aged - Does It Impact Life Expectancy? A Decision Analysis.
    PLoS One. 2016;11:e0157832.
    PubMed     Text format     Abstract available


  151. PARK SB, Seronello S, Mayer W, Ojcius DM, et al
    Hepatitis C Virus Frameshift/Alternate Reading Frame Protein Suppresses Interferon Responses Mediated by Pattern Recognition Receptor Retinoic-Acid-Inducible Gene-I.
    PLoS One. 2016;11:e0158419.
    PubMed     Text format     Abstract available


  152. LI YX, Ren YL, Fu HJ, Zou L, et al
    Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-kappaB Pathways in an ER Stress-Dependent Manner.
    PLoS One. 2016;11:e0159089.
    PubMed     Text format     Abstract available


  153. RODRIGO MB, Mojsiejczuk LN, Torres C, Sevic I, et al
    Analysis of the Molecular Evolution of Hepatitis B Virus Genotypes in Symptomatic Acute Infections in Argentina.
    PLoS One. 2016;11:e0159509.
    PubMed     Text format     Abstract available


  154. ASSELAH T, Moreno C, Sarrazin C, Gschwantler M, et al
    An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).
    PLoS One. 2016;11:e0158526.
    PubMed     Text format     Abstract available


  155. SPAAN M, Hullegie SJ, Beudeker BJ, Kreefft K, et al
    Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
    PLoS One. 2016;11:e0159243.
    PubMed     Text format     Abstract available


  156. LIN MV, Sise ME, Pavlakis M, Amundsen BM, et al
    Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0158431.
    PubMed     Text format     Abstract available


  157. YAN L, Qu S, Liu G, Liu L, et al
    Comparative Transcriptomic Analysis of Primary Duck Hepatocytes Provides Insight into Differential Susceptibility to DHBV Infection.
    PLoS One. 2016;11:e0149702.
    PubMed     Text format     Abstract available


  158. GILES DA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, et al
    Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
    PLoS One. 2016;11:e0149783.
    PubMed     Text format     Abstract available


  159. HUANG W, Zhang H, Hao Y, Xu X, et al
    A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese.
    PLoS One. 2016;11:e0148618.
    PubMed     Text format     Abstract available


  160. AZEVEDO E SILVA G, de Moura L, Curado MP, Gomes Fda S, et al
    The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020.
    PLoS One. 2016;11:e0148761.
    PubMed     Text format     Abstract available


  161. CONRAD KD, Giering F, Erfurth C, Neumann A, et al
    Correction: microRNA-122 Dependent Binding of Ago2 Protein to Hepatitis C Virus RNA Is Associated with Enhanced RNA Stability and Translation Stimulation.
    PLoS One. 2016;11:e0160132.
    PubMed     Text format     Abstract available


  162. STAHMEYER JT, Rossol S, Bert F, Boker KH, et al
    Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.
    PLoS One. 2016;11:e0159976.
    PubMed     Text format     Abstract available


  163. DEBES JD, Martinez Wassaf M, Pisano MB, Isa MB, et al
    Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+ Cell Counts in HIV-Infected Persons in Argentina.
    PLoS One. 2016;11:e0160082.
    PubMed     Text format     Abstract available


  164. IWASA S, Sato N, Wang CW, Cheng YH, et al
    The Phospholipid:Diacylglycerol Acyltransferase Lro1 Is Responsible for Hepatitis C Virus Core-Induced Lipid Droplet Formation in a Yeast Model System.
    PLoS One. 2016;11:e0159324.
    PubMed     Text format     Abstract available


  165. ZHANG YH, Zhao Y, Rajapaksa US, Lawrence TM, et al
    A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.
    PLoS One. 2016;11:e0158037.
    PubMed     Text format     Abstract available


  166. KONG FY, Wei X, Zhou K, Hu W, et al
    Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
    PLoS One. 2016;11:e0158286.
    PubMed     Text format     Abstract available


  167. CHATTERJI U, Bobardt M, Schaffer L, Wood M, et al
    Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection.
    PLoS One. 2016;11:e0159511.
    PubMed     Text format     Abstract available


  168. CHEKURI S, Nickerson J, Bichoupan K, Sefcik R, et al
    Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus.
    PLoS One. 2016;11:e0159413.
    PubMed     Text format     Abstract available


  169. ELHEFNAWI M, Kim T, Kamar MA, Min S, et al
    In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
    PLoS One. 2016;11:e0159211.
    PubMed     Text format     Abstract available


  170. SOLOMON SS, Srikrishnan AK, McFall AM, Kumar MS, et al
    Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.
    PLoS One. 2016;11:e0147879.
    PubMed     Text format     Abstract available


  171. LAUGHLIN RC, Drake KL, Morrill JC, Adams LG, et al
    Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates.
    PLoS One. 2016;11:e0147027.
    PubMed     Text format     Abstract available


  172. ZHANG QF, Shao JY, Yin WW, Xia Y, et al
    Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160171.
    PubMed     Text format     Abstract available


  173. OLIVEIRA MP, Matos MA, Silva AM, Lopes CL, et al
    Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling Survey.
    PLoS One. 2016;11:e0160916.
    PubMed     Text format     Abstract available


  174. HSIAO PJ, Hsieh PF, Chou EC, Lai HC, et al
    Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C.
    PLoS One. 2016;11:e0160450.
    PubMed     Text format     Abstract available


  175. KLIEMANN DA, Tovo CV, Gorini da Veiga AB, Machado AL, et al
    Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank.
    PLoS One. 2016;11:e0159924.
    PubMed     Text format     Abstract available


  176. BERGER KL, Sarrazin C, Nelson DR, Scherer J, et al
    Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.
    PLoS One. 2016;11:e0160668.
    PubMed     Text format     Abstract available


  177. OKPECHI IG, Ameh OI, Bello AK, Ronco P, et al
    Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0152203.
    PubMed     Text format     Abstract available


  178. CHANG TS, Chen CL, Wu YC, Liu JJ, et al
    Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0149897.
    PubMed     Text format     Abstract available


  179. VAN DER AA E, Buschow SI, Biesta PJ, Janssen HL, et al
    The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.
    PLoS One. 2016;11:e0161235.
    PubMed     Text format     Abstract available


  180. BOURGI K, Brar I, Baker-Genaw K
    Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan.
    PLoS One. 2016;11:e0161241.
    PubMed     Text format     Abstract available


  181. CHEN HJ, Huang N, Chen LS, Chou YJ, et al
    Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?
    PLoS One. 2016;11:e0161002.
    PubMed     Text format     Abstract available


  182. GOYAL A, Murray JM
    Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.
    PLoS One. 2016;11:e0161978.
    PubMed     Text format     Abstract available


  183. GARBUGLIA AR, Visco-Comandini U, Lionetti R, Lapa D, et al
    Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors.
    PLoS One. 2016;11:e0158989.
    PubMed     Text format     Abstract available


  184. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Association of Sjogrens Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0161958.
    PubMed     Text format     Abstract available


  185. KOROLOWICZ KE, Iyer RP, Czerwinski S, Suresh M, et al
    Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B.
    PLoS One. 2016;11:e0161313.
    PubMed     Text format     Abstract available


  186. ZHAO J, Zhong Q, Zhao Y, Hu YX, et al
    Correction: Pathogenicity and Complete Genome Characterization of Fowl Adenoviruses Isolated from Chickens Associated with Inclusion Body Hepatitis and Hydropericardium Syndrome in China.
    PLoS One. 2016;11:e0161744.
    PubMed     Text format     Abstract available


  187. ZHANG Z, Wang G, Kang K, Wu G, et al
    The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
    PLoS One. 2016;11:e0152757.
    PubMed     Text format     Abstract available


  188. BRADSHAW D, Raghwani J, Jacka B, Sacks-Davis R, et al
    Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.
    PLoS One. 2016;11:e0162002.
    PubMed     Text format     Abstract available


  189. KRAMER B, Finnemann C, Sastre B, Lutz P, et al
    IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C.
    PLoS One. 2016;11:e0162068.
    PubMed     Text format     Abstract available


  190. ZHANG H, Huo M, Chao J, Liu P, et al
    Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B.
    PLoS One. 2016;11:e0161936.
    PubMed     Text format     Abstract available


  191. ARAUJO OC, Rosa AS, Fernandes A, Niel C, et al
    RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    PLoS One. 2016;11:e0153796.
    PubMed     Text format     Abstract available


  192. CHEN W, Liao B, Hu F, Nie J, et al
    Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China.
    PLoS One. 2016;11:e0161844.
    PubMed     Text format     Abstract available


  193. BERDEN FA, de Knegt RJ, Blokzijl H, Kuiken SD, et al
    Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0161821.
    PubMed     Text format     Abstract available


  194. YANG Y, Ma YP, Chen DP, Zhuo L, et al
    A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    PLoS One. 2016;11:e0160437.
    PubMed     Text format     Abstract available


  195. LIU Y, Zhang S, Zhao Y, Du J, et al
    Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    PLoS One. 2016;11:e0162763.
    PubMed     Text format     Abstract available


  196. POOVORAWAN K, Pan-Ngum W, White LJ, Soonthornworasiri N, et al
    Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era.
    PLoS One. 2016;11:e0163095.
    PubMed     Text format     Abstract available


  197. JUON HS, Strong C, Kim F, Park E, et al
    Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.
    PLoS One. 2016;11:e0162683.
    PubMed     Text format     Abstract available


  198. LEI Y, Hu T, Song X, Nie H, et al
    Production of Autoantibodies in Chronic Hepatitis B Virus Infection Is Associated with the Augmented Function of Blood CXCR5+CD4+ T Cells.
    PLoS One. 2016;11:e0162241.
    PubMed     Text format     Abstract available


  199. SAMIMI-RAD K, Rahimnia R, Sadeghi M, Malekpour SA, et al
    Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran.
    PLoS One. 2016;11:e0162492.
    PubMed     Text format     Abstract available


  200. WAN Z, Chen Q, Chen X, Duo L, et al
    HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China.
    PLoS One. 2016;11:e0163062.
    PubMed     Text format     Abstract available


  201. NJOM NLEND AE, Nguwoh PS, Ngounouh CT, Tchidjou HK, et al
    HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaounde, Cameroon: An Appeal for Revised Policies in Tropical Settings?
    PLoS One. 2016;11:e0161714.
    PubMed     Text format     Abstract available


  202. PEREIRA-GOMEZ M, Bou JV, Andreu I, Sanjuan R, et al
    Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients.
    PLoS One. 2016;11:e0163363.
    PubMed     Text format     Abstract available


  203. JIMENEZ-SOUSA MA, Gutierrez-Rivas M, Alvaro-Meca A, Garcia-Alvarez M, et al
    NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in Spain.
    PLoS One. 2016;11:e0163197.
    PubMed     Text format     Abstract available


  204. IDE T, Eguchi Y, Harada M, Ishii K, et al
    Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.
    PLoS One. 2016;11:e0163884.
    PubMed     Text format     Abstract available


  205. HASHIMOTO S, Yatsuhashi H, Abiru S, Yamasaki K, et al
    Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment.
    PLoS One. 2016;11:e0163644.
    PubMed     Text format     Abstract available


  206. NGUYEN LT, Gray E, O'Leary A, Carr M, et al
    The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.
    PLoS One. 2016;11:e0163900.
    PubMed     Text format     Abstract available


  207. VAN SANTEN DK, de Vos AS, Matser A, Willemse SB, et al
    Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.
    PLoS One. 2016;11:e0163488.
    PubMed     Text format     Abstract available


  208. CAI Q, Chen K, Chen J, Wu S, et al
    The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
    PLoS One. 2016;11:e0164210.
    PubMed     Text format     Abstract available


  209. HUANG C, Lin HH, Wan JB, He C, et al
    Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations.
    PLoS One. 2016;11:e0164328.
    PubMed     Text format     Abstract available


  210. MATSUNAMI K, Nishida N, Kaneko N, Ikeo K, et al
    Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
    PLoS One. 2016;11:e0164418.
    PubMed     Text format     Abstract available


  211. COLLI A, Fraquelli M, Prati D, Riva A, et al
    Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit.
    PLoS One. 2016;11:e0164452.
    PubMed     Text format     Abstract available


  212. GHORI NU, Shafique A, Hayat MQ, Anjum S, et al
    The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population.
    PLoS One. 2016;11:e0164265.
    PubMed     Text format     Abstract available


  213. WHITE DA, Anderson ES, Pfeil SK, Deering LJ, et al
    Hepatitis C Virus Screening and Emergency Department Length of Stay.
    PLoS One. 2016;11:e0164831.
    PubMed     Text format     Abstract available


  214. DE AVILA AI, Gallego I, Soria ME, Gregori J, et al
    Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.
    PLoS One. 2016;11:e0164691.
    PubMed     Text format     Abstract available


  215. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Correction: Association of Sjogren's Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0164911.
    PubMed     Text format     Abstract available


  216. HUANG J, Zhao L, Yang P, Chen Z, et al
    Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle.
    PLoS One. 2016;11:e0164787.
    PubMed     Text format     Abstract available


  217. ALRIC L, Besson C, Lapidus N, Jeannel J, et al
    Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
    PLoS One. 2016;11:e0162965.
    PubMed     Text format     Abstract available


  218. FLISIAK R, Shiffman M, Arenas J, Cheinquer H, et al
    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
    PLoS One. 2016;11:e0164563.
    PubMed     Text format     Abstract available


  219. DAVITKOV P, Chandar AK, Hirsch A, Compan A, et al
    Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
    PLoS One. 2016;11:e0163945.
    PubMed     Text format     Abstract available


  220. CHOI YH, Jin N, Kelly F, Sakthivel SK, et al
    Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV Infection.
    PLoS One. 2016;11:e0165533.
    PubMed     Text format     Abstract available


  221. SIRAVENHA LG, Siravenha LQ, Madeira LD, Oliveira-Filho AB, et al
    Detection of HCV Persistent Infections in the Dental Pulp: A Novel Approach for the Detection of Past and Ancient Infections.
    PLoS One. 2016;11:e0165272.
    PubMed     Text format     Abstract available


  222. ITAKURA J, Kurosaki M, Hasebe C, Osaki Y, et al
    Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure.
    PLoS One. 2016;11:e0165339.
    PubMed     Text format     Abstract available


  223. MERAT SJ, Molenkamp R, Wagner K, Koekkoek SM, et al
    Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.
    PLoS One. 2016;11:e0165047.
    PubMed     Text format     Abstract available


  224. KOMATSU H, Inui A, Umetsu S, Tsunoda T, et al
    Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.
    PLoS One. 2016;11:e0165674.
    PubMed     Text format     Abstract available


  225. ZHANG Y, Cao Y, Zhang R, Zhang X, et al
    Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients.
    PLoS One. 2016;11:e0165658.
    PubMed     Text format     Abstract available


  226. LIN MT, Yen YH, Tsai MC, Tseng PL, et al
    Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice.
    PLoS One. 2016;11:e0165416.
    PubMed     Text format     Abstract available


  227. LEE D, Park SM
    Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    PLoS One. 2016;11:e0165879.
    PubMed     Text format     Abstract available


  228. LOFTFIELD E, O'Brien TR, Pfeiffer RM, Howell CD, et al
    Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.
    PLoS One. 2016;11:e0166036.
    PubMed     Text format     Abstract available


  229. SU FH, Wu CS, Sung FC, Chang SN, et al
    Correction: Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2016;11:e0166508.
    PubMed     Text format     Abstract available


  230. STENE-JOHANSEN K, Yaqoob N, Overbo J, Aberra H, et al
    Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings.
    PLoS One. 2016;11:e0166201.
    PubMed     Text format     Abstract available


  231. MIDGARD H, Bramness JG, Skurtveit S, Haukeland JW, et al
    Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.
    PLoS One. 2016;11:e0166451.
    PubMed     Text format     Abstract available


  232. PALMER BA, Fanning LJ
    Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness.
    PLoS One. 2016;11:e0167089.
    PubMed     Text format     Abstract available


  233. LEE KY, Chen YH, Hsu SC, Yu MJ, et al
    Phosphorylation of Serine 235 of the Hepatitis C Virus Non-Structural Protein NS5A by Multiple Kinases.
    PLoS One. 2016;11:e0166763.
    PubMed     Text format     Abstract available


  234. AIKEN T, Garber A, Thomas D, Hamon N, et al
    Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
    PLoS One. 2016;11:e0166998.
    PubMed     Text format     Abstract available


  235. CHANG ML, Kuo CJ, Huang HC, Chu YY, et al
    Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity.
    PLoS One. 2016;11:e0166712.
    PubMed     Text format     Abstract available


  236. GAMBATO M, Caro-Perez N, Gonzalez P, Canete N, et al
    Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
    PLoS One. 2016;11:e0166631.
    PubMed     Text format     Abstract available


  237. LEE M, Kim W, Choi Y, Kim S, et al
    Correction: Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis.
    PLoS One. 2016;11:e0167184.
    PubMed     Text format     Abstract available


  238. UMARE A, Seyoum B, Gobena T, Haile Mariyam T, et al
    Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia.
    PLoS One. 2016;11:e0166936.
    PubMed     Text format     Abstract available


  239. HAMAD HA, Thurston J, Teague T, Ackad E, et al
    The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region.
    PLoS One. 2016;11:e0168002.
    PubMed     Text format     Abstract available


  240. JEON I, Cho ES, Kim JH, Kim DJ, et al
    Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30 degrees Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.
    PLoS One. 2016;11:e0167701.
    PubMed     Text format     Abstract available


  241. CHIEN TL, Wang JH, Kee KM, Chen CH, et al
    Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
    PLoS One. 2016;11:e0166543.
    PubMed     Text format     Abstract available


  242. PUIGVEHI M, Hernandez J, Broquetas T, Coll S, et al
    Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF(R)) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
    PLoS One. 2016;11:e0164883.
    PubMed     Text format     Abstract available


  243. VIARD JP, Assuied A, Levy Y, Souberbielle JC, et al
    No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults.
    PLoS One. 2016;11:e0168640.
    PubMed     Text format     Abstract available


  244. NUNEZ-TORRES R, Macias J, Mancebo M, Frias M, et al
    The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    PLoS One. 2016;11:e0168265.
    PubMed     Text format     Abstract available


  245. SARRAZIN C, Manns M, Calleja JL, Garcia-Samaniego J, et al
    HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.
    PLoS One. 2016;11:e0168544.
    PubMed     Text format     Abstract available


  246. EL-GHITANY EM, Farghaly AG, Farag S, Abd El-Wahab EW, et al
    Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.
    PLoS One. 2016;11:e0168649.
    PubMed     Text format     Abstract available


  247. VILLANI R, Facciorusso A, Bellanti F, Tamborra R, et al
    DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.
    PLoS One. 2016;11:e0167934.
    PubMed     Text format     Abstract available


  248. CHUNG JW, Kim BH, Lee CS, Kim GH, et al
    Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
    PLoS One. 2016;11:e0168189.
    PubMed     Text format     Abstract available


  249. HUANG YS, Chang SY, Sheng WH, Sun HY, et al
    Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
    PLoS One. 2016;11:e0169228.
    PubMed     Text format     Abstract available


    January 2015
  250. PFEIL AM, Reich O, Guerra IM, Cure S, et al
    Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C.
    PLoS One. 2015;10:e0126984.
    PubMed     Text format     Abstract available


  251. CHEN CY, Huang SY, Cheng A, Chou WC, et al
    High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia.
    PLoS One. 2015;10:e0126037.
    PubMed     Text format     Abstract available


  252. KUO YH, Chen PF, Wang JH, Chang KC, et al
    Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care.
    PLoS One. 2015;10:e0126031.
    PubMed     Text format     Abstract available


  253. ALHAMMAD YM, Maharajh S, Butcher R, Eden JS, et al
    Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection.
    PLoS One. 2015;10:e0126397.
    PubMed     Text format     Abstract available


  254. CHU PS, Ebinuma H, Nakamoto N, Sugiyama K, et al
    Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/ Ribavirin Therapy in Chronic Hepatitis C.
    PLoS One. 2015;10:e0125664.
    PubMed     Text format     Abstract available


  255. RAJALAKSHMY AR, Malathi J, Madhavan HN
    Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-kappaB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    PLoS One. 2015;10:e0125419.
    PubMed     Text format     Abstract available


  256. WASITTHANKASEM R, Vongpunsawad S, Siripon N, Suya C, et al
    Genotypic distribution of hepatitis C virus in Thailand and southeast Asia.
    PLoS One. 2015;10:e0126764.
    PubMed     Text format     Abstract available


  257. BROUARD C, Le Strat Y, Larsen C, Jauffret-Roustide M, et al
    The undiagnosed chronically-infected HCV population in france. Implications for expanded testing recommendations in 2014.
    PLoS One. 2015;10:e0126920.
    PubMed     Text format     Abstract available


  258. KURT R, Chandra PK, Aboulnasr F, Panigrahi R, et al
    Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    PLoS One. 2015;10:e0125962.
    PubMed     Text format     Abstract available


  259. ZHANG H, Huang C, Wang Y, Lu Z, et al
    Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20.
    PLoS One. 2015;10:e0127329.
    PubMed     Text format     Abstract available


  260. RODRIGUEZ LAY LA, Corredor MB, Villalba MC, Frometa SS, et al
    Genetic Diversity of the Hepatitis B Virus Strains in Cuba: Absence of West-African Genotypes despite the Transatlantic Slave Trade.
    PLoS One. 2015;10:e0125052.
    PubMed     Text format     Abstract available


  261. DE RE V, Caggiari L, De Zorzi M, Repetto O, et al
    Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.
    PLoS One. 2015;10:e0128849.
    PubMed     Text format     Abstract available


  262. MCDONALD SA, Dahlui M, Mohamed R, Naning H, et al
    Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia.
    PLoS One. 2015;10:e0128091.
    PubMed     Text format     Abstract available


  263. TSAI CF, Chu CJ, Huang YH, Wang YP, et al
    Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
    PLoS One. 2015;10:e0128437.
    PubMed     Text format     Abstract available


  264. MUTSO M, Nikonov A, Pihlak A, Zusinaite E, et al
    RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.
    PLoS One. 2015;10:e0128686.
    PubMed     Text format     Abstract available


  265. MATHEW S, Fatima K, Fatmi MQ, Archunan G, et al
    Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
    PLoS One. 2015;10:e0126510.
    PubMed     Text format     Abstract available


  266. BANSAL R, Frelin L, Brenndorfer ED, Storm G, et al
    Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
    PLoS One. 2015;10:e0128466.
    PubMed     Text format     Abstract available


  267. TACHTATZIS PM, Marshall A, Aravinthan A, Verma S, et al
    Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
    PLoS One. 2015;10:e0127511.
    PubMed     Text format     Abstract available


  268. TANG W, Chen L, Zheng R, Pan L, et al
    Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis.
    PLoS One. 2015;10:e0128673.
    PubMed     Text format     Abstract available


  269. LEE HW, Chang DY, Moon HJ, Chang HY, et al
    Clinical Factors and Viral Load Influencing Severity of Acute Hepatitis A.
    PLoS One. 2015;10:e0130728.
    PubMed     Text format     Abstract available


  270. ROLLET-KURHAJEC KC, Moodie EE, Walmsley S, Cooper C, et al
    Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection - The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    PLoS One. 2015;10:e0129868.
    PubMed     Text format     Abstract available


  271. YOSHIMI S, Ochi H, Murakami E, Uchida T, et al
    Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay.
    PLoS One. 2015;10:e0130022.
    PubMed     Text format     Abstract available


  272. CUI X, McAllister R, Boregowda R, Sohn JA, et al
    Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?
    PLoS One. 2015;10:e0128401.
    PubMed     Text format     Abstract available


  273. MCELROY A, Hiraide R, Bexfield N, Jalal H, et al
    Detection of Hepatitis E Virus Antibodies in Dogs in the United Kingdom.
    PLoS One. 2015;10:e0128703.
    PubMed     Text format     Abstract available


  274. YE L, Yu H, Li C, Hirsch ML, et al
    Adeno-Associated Virus Vector Mediated Delivery of the HBV Genome Induces Chronic Hepatitis B Virus Infection and Liver Fibrosis in Mice.
    PLoS One. 2015;10:e0130052.
    PubMed     Text format     Abstract available


  275. CHEN F, Sun D, Guo Y, Guo W, et al
    Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012.
    PLoS One. 2015;10:e0129746.
    PubMed     Text format     Abstract available


  276. SASAKI R, Yamasaki K, Abiru S, Komori A, et al
    Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
    PLoS One. 2015;10:e0129053.
    PubMed     Text format     Abstract available


  277. KERUBO G, Khamadi S, Okoth V, Madise N, et al
    Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.
    PLoS One. 2015;10:e0129247.
    PubMed     Text format     Abstract available


  278. PFAFFEROTT K, Deshpande P, McKinnon E, Merani S, et al
    Anti-Hepatitis C Virus T-Cell Immunity in the Context of Multiple Exposures to the Virus.
    PLoS One. 2015;10:e0130420.
    PubMed     Text format     Abstract available


  279. MULLHAUPT B, Bruggmann P, Bihl F, Blach S, et al
    Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.
    PLoS One. 2015;10:e0125214.
    PubMed     Text format     Abstract available


  280. JIANG X, Kanda T, Wu S, Nakamoto S, et al
    Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-kappaB-Nuclear Translocation.
    PLoS One. 2015;10:e0131973.
    PubMed     Text format     Abstract available


  281. CHEN YF, Chong CL, Wu YC, Wang YL, et al
    Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPalpha Expression.
    PLoS One. 2015;10:e0131743.
    PubMed     Text format     Abstract available


  282. CHEN WC, Cheng JS, Chiang PH, Tsay FW, et al
    A Comparison of Entecavir and Lamivudine for the Prophylaxis of Hepatitis B Virus Reactivation in Solid Tumor Patients Undergoing Systemic Cytotoxic Chemotherapy.
    PLoS One. 2015;10:e0131545.
    PubMed     Text format     Abstract available


  283. CHO EJ, Lee JH, Cho Y, Lee YB, et al
    Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients.
    PLoS One. 2015;10:e0130392.
    PubMed     Text format     Abstract available


  284. URAKI S, Tameda M, Sugimoto K, Shiraki K, et al
    Substitution in Amino Acid 70 of Hepatitis C Virus Core Protein Changes the Adipokine Profile via Toll-Like Receptor 2/4 Signaling.
    PLoS One. 2015;10:e0131346.
    PubMed     Text format     Abstract available


  285. YUAN Q, Song LW, Cavallone D, Moriconi F, et al
    Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    PLoS One. 2015;10:e0130209.
    PubMed     Text format     Abstract available


  286. DOMAGALSKI K, Pawlowska M, Kozielewicz D, Dybowska D, et al
    The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.
    PLoS One. 2015;10:e0130899.
    PubMed     Text format     Abstract available


  287. OLUYINKA OO, Tong HV, Bui Tien S, Fagbami AH, et al
    Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    PLoS One. 2015;10:e0131912.
    PubMed     Text format     Abstract available


  288. LIU S, Chen R, Hagedorn CH
    Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells.
    PLoS One. 2015;10:e0131358.
    PubMed     Text format     Abstract available


  289. PARK EM, Lim YS, Ahn BY, Hwang SB, et al
    AAM-B Interacts with Nonstructural 4B and Regulates Hepatitis C Virus Propagation.
    PLoS One. 2015;10:e0132839.
    PubMed     Text format     Abstract available


  290. MEISSNER EG, Decalf J, Casrouge A, Masur H, et al
    Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.
    PLoS One. 2015;10:e0133236.
    PubMed     Text format     Abstract available


  291. WANG H, Ji F, Liang H, Gu H, et al
    A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.
    PLoS One. 2015;10:e0133282.
    PubMed     Text format     Abstract available


  292. BRAUN DL, Rauch A, Aouri M, Durisch N, et al
    A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
    PLoS One. 2015;10:e0133028.
    PubMed     Text format     Abstract available


  293. MA X, Sheng Z, Huang B, Qi L, et al
    Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability.
    PLoS One. 2015;10:e0132982.
    PubMed     Text format     Abstract available


  294. ZHAO J, Zhong Q, Zhao Y, Hu YX, et al
    Pathogenicity and Complete Genome Characterization of Fowl Adenoviruses Isolated from Chickens Associated with Inclusion Body Hepatitis and Hydropericardium Syndrome in China.
    PLoS One. 2015;10:e0133073.
    PubMed     Text format     Abstract available


  295. GUNDLAPALLI AV, Nelson RE, Haroldsen C, Carter ME, et al
    Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009.
    PLoS One. 2015;10:e0132056.
    PubMed     Text format     Abstract available


  296. THEDJA MD, Muljono DH, Ie SI, Sidarta E, et al
    Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific.
    PLoS One. 2015;10:e0132533.
    PubMed     Text format     Abstract available


  297. QI Y, Zhang F, Zhang L, Harrison TJ, et al
    Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope.
    PLoS One. 2015;10:e0132503.
    PubMed     Text format     Abstract available


  298. MWATELAH RS, Lwembe RM, Osman S, Ogutu BR, et al
    Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.
    PLoS One. 2015;10:e0132287.
    PubMed     Text format     Abstract available


  299. XIE Y, Liu S, Zhao Y, Zhang L, et al
    Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0133393.
    PubMed     Text format     Abstract available



  300. Correction: Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-kappaB-Nuclear Translocation.
    PLoS One. 2015;10:e0134068.
    PubMed     Text format     Abstract available


  301. JIN H, Tan Z, Zhang X, Wang B, et al
    Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2015;10:e0133464.
    PubMed     Text format     Abstract available


  302. LIU B, Chen S, Guan Y, Chen L, et al
    Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    PLoS One. 2015;10:e0133800.
    PubMed     Text format     Abstract available


  303. KERUBO G, Khamadi S, Okoth V, Madise N, et al
    Correction: Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.
    PLoS One. 2015;10:e0133342.
    PubMed     Text format     Abstract available


  304. LAMOURY FM, Jacka B, Bartlett S, Bull RA, et al
    The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis.
    PLoS One. 2015;10:e0131437.
    PubMed     Text format     Abstract available


  305. CHEN WC, Tseng CK, Chen YH, Lin CK, et al
    HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway.
    PLoS One. 2015;10:e0133264.
    PubMed     Text format     Abstract available


  306. HOFMANN WP, Mauss S, Lutz T, Schober A, et al
    Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study.
    PLoS One. 2015;10:e0134839.
    PubMed     Text format     Abstract available


  307. MARTINEZ AA, Zaldivar Y, Arteaga G, de Castillo Z, et al
    Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country.
    PLoS One. 2015;10:e0134850.
    PubMed     Text format     Abstract available


  308. GONG X, Yang J, Tang J, Gu C, et al
    A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B.
    PLoS One. 2015;10:e0134532.
    PubMed     Text format     Abstract available


  309. HUEGING K, Weller R, Doepke M, Vieyres G, et al
    Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.
    PLoS One. 2015;10:e0134529.
    PubMed     Text format     Abstract available


  310. XIE QL, Zhu Y, Wu LH, Fu LL, et al
    The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis.
    PLoS One. 2015;10:e0132219.
    PubMed     Text format     Abstract available


  311. INSHAW J, Leen C, Fisher M, Gilson R, et al
    The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.
    PLoS One. 2015;10:e0132772.
    PubMed     Text format     Abstract available


  312. KOVARI H, Russmann S, Ledergerber B, Muller D, et al
    Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
    PLoS One. 2015;10:e0133879.
    PubMed     Text format     Abstract available


  313. MATTHEWS PC, Beloukas A, Malik A, Carlson JM, et al
    Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.
    PLoS One. 2015;10:e0134037.
    PubMed     Text format     Abstract available


  314. TACHTATZIS PM, Marshall A, Aravinthan A, Verma S, et al
    Correction: Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
    PLoS One. 2015;10:e0134315.
    PubMed     Text format     Abstract available


  315. GUO P, Zeng F, Hu X, Zhang D, et al
    Improved Variable Selection Algorithm Using a LASSO-Type Penalty, with an Application to Assessing Hepatitis B Infection Relevant Factors in Community Residents.
    PLoS One. 2015;10:e0134151.
    PubMed     Text format     Abstract available


  316. AOUDJEHANE L, Bisch G, Scatton O, Granier C, et al
    Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.
    PLoS One. 2015;10:e0134141.
    PubMed     Text format     Abstract available


  317. TACHI Y, Hirai T, Toyoda H, Tada T, et al
    Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
    PLoS One. 2015;10:e0133515.
    PubMed     Text format     Abstract available



  318. Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
    PLoS One. 2015;10:e0135547.
    PubMed     Text format     Abstract available


  319. RUDLER M, Mouri S, Charlotte F, Cluzel P, et al
    Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.
    PLoS One. 2015;10:e0134302.
    PubMed     Text format     Abstract available


  320. CHOO MK, El-Bassel N, Adam PC, Gilbert L, et al
    Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen.
    PLoS One. 2015;10:e0118422.
    PubMed     Text format     Abstract available


  321. DOLD L, Ahlenstiel G, Althausen E, Luda C, et al
    Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    PLoS One. 2015;10:e0134158.
    PubMed     Text format     Abstract available


  322. ZOU Y, Bao J, Pan X, Lu Y, et al
    NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
    PLoS One. 2015;10:e0134568.
    PubMed     Text format     Abstract available


  323. GALLAY PA, Bobardt MD, Chatterji U, Trepanier DJ, et al
    The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.
    PLoS One. 2015;10:e0134707.
    PubMed     Text format     Abstract available


  324. KINKEL HT, Karmacharya D, Shakya J, Manandhar S, et al
    Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.
    PLoS One. 2015;10:e0134455.
    PubMed     Text format     Abstract available


  325. KWON E, Cho JH, Jang HM, Kim YS, et al
    Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.
    PLoS One. 2015;10:e0135476.
    PubMed     Text format     Abstract available


  326. LI W, Jiang Y, Wang X, Jin J, et al
    Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    PLoS One. 2015;10:e0135874.
    PubMed     Text format     Abstract available


  327. CHEN F, Sun D, Guo Y, Guo W, et al
    Correction: Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012.
    PLoS One. 2015;10:e0136333.
    PubMed     Text format     Abstract available


  328. GUSATTI CS, Costi C, Halon ML, Grandi T, et al
    Hepatitis B Virus Genotype D Isolates Circulating in Chapeco, Southern Brazil, Originate from Italy.
    PLoS One. 2015;10:e0135816.
    PubMed     Text format     Abstract available


  329. STRASSL R, Rutter K, Stattermayer AF, Beinhardt S, et al
    Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy.
    PLoS One. 2015;10:e0135963.
    PubMed     Text format     Abstract available


  330. WANG Y, McGivern DR, Cheng L, Li G, et al
    Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production.
    PLoS One. 2015;10:e0135232.
    PubMed     Text format     Abstract available


  331. BALAGOPAL A, Barin B, Quinn J, Rogers R, et al
    Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons.
    PLoS One. 2015;10:e0135882.
    PubMed     Text format     Abstract available


  332. READ SA, Tay ES, Shahidi M, O'Connor KS, et al
    Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.
    PLoS One. 2015;10:e0136227.
    PubMed     Text format     Abstract available


  333. DO A, Mittal Y, Liapakis A, Cohen E, et al
    Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade.
    PLoS One. 2015;10:e0135645.
    PubMed     Text format     Abstract available


  334. CHEMAITELLY H, Chaabna K, Abu-Raddad LJ
    The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0135281.
    PubMed     Text format     Abstract available


  335. ECHEVARRIA D, Gutfraind A, Boodram B, Major M, et al
    Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.
    PLoS One. 2015;10:e0135901.
    PubMed     Text format     Abstract available


  336. THANAPIROM K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, et al
    Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
    PLoS One. 2015;10:e0137365.
    PubMed     Text format     Abstract available


  337. ETIENNE L, Blanchard E, Boyer A, Desvignes V, et al
    The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion.
    PLoS One. 2015;10:e0137182.
    PubMed     Text format     Abstract available


  338. KONG LN, Guo Y, Qin B, Peng X, et al
    Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel Survey.
    PLoS One. 2015;10:e0134125.
    PubMed     Text format     Abstract available


  339. PENG J, Lu Y, Liu W, Zhu Y, et al
    Genotype Distribution and Molecular Epidemiology of Hepatitis C Virus in Hubei, Central China.
    PLoS One. 2015;10:e0137059.
    PubMed     Text format     Abstract available


  340. AHN SH, Kim DH, Lee AR, Kim BK, et al
    Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.
    PLoS One. 2015;10:e0136728.
    PubMed     Text format     Abstract available


  341. DALGARD O, Martinot-Peignoux M, Verbaan H, Bjoro K, et al
    The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection.
    PLoS One. 2015;10:e0120866.
    PubMed     Text format     Abstract available


  342. DIETZ J, Susser S, Berkowski C, Perner D, et al
    Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.
    PLoS One. 2015;10:e0134395.
    PubMed     Text format     Abstract available


  343. YAMADA H, Takahashi K, Lim O, Svay S, et al
    Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4.
    PLoS One. 2015;10:e0136903.
    PubMed     Text format     Abstract available


  344. MOTAWI TK, Shaker OG, El-Maraghy SA, Senousy MA, et al
    Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    PLoS One. 2015;10:e0137706.
    PubMed     Text format     Abstract available


  345. TAMAKI N, Kurosaki M, Higuchi M, Takada H, et al
    Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens.
    PLoS One. 2015;10:e0137351.
    PubMed     Text format     Abstract available


  346. KAUHL B, Heil J, Hoebe CJ, Schweikart J, et al
    The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants-An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.
    PLoS One. 2015;10:e0135656.
    PubMed     Text format     Abstract available


  347. KOLB P, Wallich R, Nassal M
    Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.
    PLoS One. 2015;10:e0136180.
    PubMed     Text format     Abstract available


  348. MAZZARA S, Sinisi A, Cardaci A, Rossi RL, et al
    Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis.
    PLoS One. 2015;10:e0137927.
    PubMed     Text format     Abstract available


  349. NOUBIAP JJ, Aka PV, Nanfack AJ, Agyingi LA, et al
    Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade.
    PLoS One. 2015;10:e0137375.
    PubMed     Text format     Abstract available


  350. BARANYI A, Meinitzer A, Breitenecker RJ, Amouzadeh-Ghadikolai O, et al
    Quinolinic Acid Responses during Interferon-alpha-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis.
    PLoS One. 2015;10:e0137022.
    PubMed     Text format     Abstract available


  351. ITAKURA J, Kurosaki M, Higuchi M, Takada H, et al
    Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy.
    PLoS One. 2015;10:e0138060.
    PubMed     Text format     Abstract available


  352. YANG CC, Tsai WL, Su WW, Huang CF, et al
    Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.
    PLoS One. 2015;10:e0137852.
    PubMed     Text format     Abstract available


  353. GAO Y, Zhang M, Li J, Yang M, et al
    Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation.
    PLoS One. 2015;10:e0137881.
    PubMed     Text format     Abstract available



  354. Correction: Correction: Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012.
    PLoS One. 2015;10:e0139180.
    PubMed     Text format     Abstract available


  355. LEPIDA A, Colombo M, Fernandez I, Abdurakhmanov D, et al
    Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis.
    PLoS One. 2015;10:e0138503.
    PubMed     Text format     Abstract available


  356. THEIN HH, Campitelli MA, Yeung LT, Zaheen A, et al
    Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    PLoS One. 2015;10:e0138907.
    PubMed     Text format     Abstract available


  357. COILLY A, Dumortier J, Botta-Fridlund D, Latournerie M, et al
    Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
    PLoS One. 2015;10:e0138091.
    PubMed     Text format     Abstract available


  358. LEE Z, Nishikawa S, Gao S, Eksteen JB, et al
    Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.
    PLoS One. 2015;10:e0137568.
    PubMed     Text format     Abstract available


  359. YU G, Chi X, Wu R, Wang X, et al
    Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
    PLoS One. 2015;10:e0139015.
    PubMed     Text format     Abstract available


  360. GUTFRAIND A, Boodram B, Prachand N, Hailegiorgis A, et al
    Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections.
    PLoS One. 2015;10:e0137993.
    PubMed     Text format     Abstract available


  361. ZHANG AY, Lai CL, Huang FY, Seto WK, et al
    Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0139478.
    PubMed     Text format     Abstract available



  362. Correction: Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.
    PLoS One. 2015;10:e0139818.
    PubMed     Text format     Abstract available


  363. SCHMID P, Bregenzer A, Huber M, Rauch A, et al
    Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
    PLoS One. 2015;10:e0138838.
    PubMed     Text format     Abstract available


  364. NIELSEN MJ, Kazankov K, Leeming DJ, Karsdal MA, et al
    Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.
    PLoS One. 2015;10:e0137302.
    PubMed     Text format     Abstract available


  365. OSIOWY C, Giles E, Trubnikov M, Choudhri Y, et al
    Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada.
    PLoS One. 2015;10:e0136074.
    PubMed     Text format     Abstract available


  366. DENG K, Liu R, Rao H, Jiang D, et al
    Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    PLoS One. 2015;10:e0138756.
    PubMed     Text format     Abstract available


  367. CHERONI C, Donnici L, Aghemo A, Balistreri F, et al
    Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity.
    PLoS One. 2015;10:e0138546.
    PubMed     Text format     Abstract available


  368. XIE DD, Li J, Chen JT, Eyi UM, et al
    Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Treponema pallidum Infections among Blood Donors on Bioko Island, Equatorial Guinea.
    PLoS One. 2015;10:e0139947.
    PubMed     Text format     Abstract available


  369. MAAN R, van der Meer AJ, Brouwer WP, Plompen EP, et al
    ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection.
    PLoS One. 2015;10:e0139317.
    PubMed     Text format     Abstract available


  370. LO YC, Tsai MS, Sun HY, Hung CC, et al
    National Trend and Characteristics of Acute Hepatitis C among HIV-Infected Individuals: A Matched Case-Control Study-Taiwan, 2001-2014.
    PLoS One. 2015;10:e0139687.
    PubMed     Text format     Abstract available


  371. KIM H, Gong JR, Lee SA, Kim BJ, et al
    Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals.
    PLoS One. 2015;10:e0139551.
    PubMed     Text format     Abstract available


  372. VANIER G, Hempel F, Chan P, Rodamer M, et al
    Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum.
    PLoS One. 2015;10:e0139282.
    PubMed     Text format     Abstract available


  373. WAN Z, Wu Y, Yi J, You S, et al
    Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure.
    PLoS One. 2015;10:e0116968.
    PubMed     Text format     Abstract available


  374. WU WP, Chou CT, Chen RC, Lee CW, et al
    Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C.
    PLoS One. 2015;10:e0140068.
    PubMed     Text format     Abstract available


  375. MOROZOV VA, Morozov AV, Rotem A, Barkai U, et al
    Extended Microbiological Characterization of Gottingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus.
    PLoS One. 2015;10:e0139893.
    PubMed     Text format     Abstract available


  376. TAO J, Liang J, Zhang H, Pei L, et al
    The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China.
    PLoS One. 2015;10:e0140263.
    PubMed     Text format     Abstract available


  377. CHEN SH, Peng CY, Lai HC, Chang IP, et al
    Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C.
    PLoS One. 2015;10:e0140554.
    PubMed     Text format     Abstract available


  378. POIZOT-MARTIN I, Naqvi A, Obry-Roguet V, Valantin MA, et al
    Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
    PLoS One. 2015;10:e0141164.
    PubMed     Text format     Abstract available


  379. VIRINE B, Osiowy C, Gao S, Wang T, et al
    Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
    PLoS One. 2015;10:e0140070.
    PubMed     Text format     Abstract available


  380. CHEN AY, Hoare M, Shankar AN, Allison M, et al
    Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis C.
    PLoS One. 2015;10:e0140312.
    PubMed     Text format     Abstract available


  381. CAI Q, Zhang X, Lin C, Shao X, et al
    24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial.
    PLoS One. 2015;10:e0140853.
    PubMed     Text format     Abstract available


  382. HUANG J, Ou HY, Lin J, Karnchanasorn R, et al
    The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination.
    PLoS One. 2015;10:e0139730.
    PubMed     Text format     Abstract available


  383. STEFAS I, Tigrett S, Dubois G, Kaiser M, et al
    Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus.
    PLoS One. 2015;10:e0140900.
    PubMed     Text format     Abstract available


  384. XU S, Wang Q, Zhang W, Qiu Z, et al
    Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study.
    PLoS One. 2015;10:e0140854.
    PubMed     Text format     Abstract available


  385. SONG YJ, Lim J, Park WS, Sohn H, et al
    Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus.
    PLoS One. 2015;10:e0142297.
    PubMed     Text format     Abstract available


  386. LIU L, Zhang J, Lu Y, Fang C, et al
    Correlations between ASCC3 Gene Polymorphisms and Chronic Hepatitis B in a Chinese Han Population.
    PLoS One. 2015;10:e0141861.
    PubMed     Text format     Abstract available


  387. TOY M, Hutton DW, So SK
    Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China.
    PLoS One. 2015;10:e0139876.
    PubMed     Text format     Abstract available


  388. BINKA M, Paintsil E, Patel A, Lindenbach BD, et al
    Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.
    PLoS One. 2015;10:e0139737.
    PubMed     Text format     Abstract available


  389. WADE AJ, Macdonald DM, Doyle JS, Gordon A, et al
    The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.
    PLoS One. 2015;10:e0142770.
    PubMed     Text format     Abstract available


  390. CHEN M, Ma Y, Chen H, Luo H, et al
    Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics.
    PLoS One. 2015;10:e0142543.
    PubMed     Text format     Abstract available


  391. FENEANT L, Ghosn J, Fouquet B, Helle F, et al
    Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    PLoS One. 2015;10:e0142539.
    PubMed     Text format     Abstract available


  392. NOORDEEN F, Scougall CA, Grosse A, Qiao Q, et al
    Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
    PLoS One. 2015;10:e0140909.
    PubMed     Text format     Abstract available


  393. GREENAWAY C, Thu Ma A, Kloda LA, Klein M, et al
    The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0141715.
    PubMed     Text format     Abstract available


  394. ZHU F, Chen T, Zhang Y, Sun H, et al
    A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.
    PLoS One. 2015;10:e0142349.
    PubMed     Text format     Abstract available


  395. JANSEN K, Thamm M, Bock CT, Scheufele R, et al
    High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.
    PLoS One. 2015;10:e0142515.
    PubMed     Text format     Abstract available


  396. VARGAS CL, Espinoza MA, Giglio A, Soza A, et al
    Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile.
    PLoS One. 2015;10:e0141660.
    PubMed     Text format     Abstract available


  397. YE F, Xin Z, Han W, Fan J, et al
    Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines.
    PLoS One. 2015;10:e0142082.
    PubMed     Text format     Abstract available


  398. MIGITA K, Komori A, Kozuru H, Jiuchi Y, et al
    Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
    PLoS One. 2015;10:e0136908.
    PubMed     Text format     Abstract available


  399. SARKAR N, Pal A, Das D, Saha D, et al
    Virological Characteristics of Acute Hepatitis B in Eastern India: Critical Differences with Chronic Infection.
    PLoS One. 2015;10:e0141741.
    PubMed     Text format     Abstract available


  400. FOUQUET B, Ghosn J, Quertainmont Y, Salmon D, et al
    Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study.
    PLoS One. 2015;10:e0142698.
    PubMed     Text format     Abstract available



  401. Correction: Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel Survey.
    PLoS One. 2015;10:e0143464.
    PubMed     Text format     Abstract available


  402. AMANZADA A, Reinhardt L, Fey D, Zeisberg EM, et al
    Hepatic Interferon-lambda3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
    PLoS One. 2015;10:e0143783.
    PubMed     Text format     Abstract available


  403. ZHANG X, Zhai L, Rong C, Qin X, et al
    Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.
    PLoS One. 2015;10:e0143069.
    PubMed     Text format     Abstract available


  404. SCHEINER B, Mandorfer M, Schwabl P, Payer BA, et al
    The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    PLoS One. 2015;10:e0143429.
    PubMed     Text format     Abstract available


  405. AN HAACK I, Derkow K, Riehn M, Rentinck MN, et al
    The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
    PLoS One. 2015;10:e0143715.
    PubMed     Text format     Abstract available


  406. HE YF, Wang CQ, Yu Y, Qian J, et al
    Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
    PLoS One. 2015;10:e0143657.
    PubMed     Text format     Abstract available


  407. WANG ZS, Guo WD, Wu LQ, Yi X, et al
    Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    PLoS One. 2015;10:e0142727.
    PubMed     Text format     Abstract available


  408. LIMA VD, Rozada I, Grebely J, Hull M, et al
    Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
    PLoS One. 2015;10:e0143836.
    PubMed     Text format     Abstract available


  409. GREENAWAY C, Ma AT, Kloda LA, Klein M, et al
    Correction: The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0144567.
    PubMed     Text format     Abstract available


  410. ASSELAH T, Zeuzem S, Soriano V, Bronowicki JP, et al
    ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
    PLoS One. 2015;10:e0144004.
    PubMed     Text format     Abstract available


  411. REYES-AVILES E, Kostadinova L, Rusterholtz A, Cruz-Lebron A, et al
    Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy.
    PLoS One. 2015;10:e0144629.
    PubMed     Text format     Abstract available


  412. MACIAS J, Lopez-Cortes LF, Tellez F, Recio E, et al
    Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.
    PLoS One. 2015;10:e0143492.
    PubMed     Text format     Abstract available


  413. MUSSINI C, Lorenzini P, Puoti M, Lichtner M, et al
    Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    PLoS One. 2015;10:e0140877.
    PubMed     Text format     Abstract available


  414. ABOUT F, Oudot-Mellakh T, Niay J, Rabiega P, et al
    Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
    PLoS One. 2015;10:e0145105.
    PubMed     Text format     Abstract available


  415. YOKOYAMA Y, Miyagi T, Hikita H, Yoshioka T, et al
    The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice.
    PLoS One. 2015;10:e0144775.
    PubMed     Text format     Abstract available


  416. ABOULNASR F, Hazari S, Nayak S, Chandra PK, et al
    IFN-lambda Inhibits MiR-122 Transcription through a Stat3-HNF4alpha Inflammatory Feedback Loop in an IFN-alpha Resistant HCV Cell Culture System.
    PLoS One. 2015;10:e0141655.
    PubMed     Text format     Abstract available


  417. PAULSEN D, Weber O, Ruebsamen-Schaeff H, Tennant BC, et al
    AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.
    PLoS One. 2015;10:e0144383.
    PubMed     Text format     Abstract available


  418. BINKA M, Paintsil E, Patel A, Lindenbach BD, et al
    Correction: Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.
    PLoS One. 2015;10:e0146088.
    PubMed     Text format     Abstract available


  419. CHENG X, Guan W, Sun S, Li B, et al
    Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.
    PLoS One. 2015;10:e0145746.
    PubMed     Text format     Abstract available


  420. WIEGAND SB, Heidrich B, Susser S, Rogalska-Taranta M, et al
    Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
    PLoS One. 2015;10:e0145622.
    PubMed     Text format     Abstract available


  421. AHN JM, Sinn DH, Gwak GY, Paik YH, et al
    Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
    PLoS One. 2015;10:e0144777.
    PubMed     Text format     Abstract available


  422. VIRINE B, Osiowy C, Gao S, Wang T, et al
    Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up.
    PLoS One. 2015;10:e0145898.
    PubMed     Text format     Abstract available


  423. AMADO LEON LA, de Almeida AJ, de Paula VS, Tourinho RS, et al
    Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study.
    PLoS One. 2015;10:e0145454.
    PubMed     Text format     Abstract available


  424. GEUE C, Wu O, Xin Y, Heggie R, et al
    Cost-Effectiveness of HBV and HCV Screening Strategies - A Systematic Review of Existing Modelling Techniques.
    PLoS One. 2015;10:e0145022.
    PubMed     Text format     Abstract available


  425. FORBI JC, Layden JE, Phillips RO, Mora N, et al
    Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana.
    PLoS One. 2015;10:e0145530.
    PubMed     Text format     Abstract available


  426. SUWANTHAWORNKUL T, Anothaisintawee T, Sobhonslidsuk A, Thakkinstian A, et al
    Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naive Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis.
    PLoS One. 2015;10:e0145953.
    PubMed     Text format     Abstract available


  427. GRAUMANN F, Churin Y, Tschuschner A, Reifenberg K, et al
    Genomic Methylation Inhibits Expression of Hepatitis B Virus Envelope Protein in Transgenic Mice: A Non-Infectious Mouse Model to Study Silencing of HBV Surface Antigen Genes.
    PLoS One. 2015;10:e0146099.
    PubMed     Text format     Abstract available


  428. DASSAH S, Sakyi SA, Frempong MT, Luuse AT, et al
    Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study.
    PLoS One. 2015;10:e0145209.
    PubMed     Text format     Abstract available


  429. CABALLERO A, Gregori J, Homs M, Tabernero D, et al
    Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus.
    PLoS One. 2015;10:e0144816.
    PubMed     Text format     Abstract available


  430. ZHANG YY
    Duck Hepatitis B Virus cccDNA Amplification Efficiency in Natural Infection Is Regulated by Virus Secretion Efficiency.
    PLoS One. 2015;10:e0145465.
    PubMed     Text format     Abstract available


  431. CHENG J, Hou J, Ding H, Chen G, et al
    Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.
    PLoS One. 2015;10:e0144425.
    PubMed     Text format     Abstract available


  432. SCHARTON D, Van Wettere AJ, Bailey KW, Vest Z, et al
    Rift Valley fever virus infection in golden Syrian hamsters.
    PLoS One. 2015;10:e0116722.
    PubMed     Text format     Abstract available


  433. RYCROFT D, Sosabowski J, Coulstock E, Davies M, et al
    Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.
    PLoS One. 2015;10:e0117847.
    PubMed     Text format     Abstract available


  434. JIA Y, Zeng Z, Li Y, Li Z, et al
    Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.
    PLoS One. 2015;10:e0117458.
    PubMed     Text format     Abstract available


  435. DENG Y, Xie M, Xie L, Wang J, et al
    Association between polymorphism of the interleukin-13 gene and susceptibility to hepatocellular carcinoma in the Chinese population.
    PLoS One. 2015;10:e0116682.
    PubMed     Text format     Abstract available


  436. DE MONTEYNARD LA, Dray-Spira R, de Truchis P, Grabar S, et al
    Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
    PLoS One. 2015;10:e0118492.
    PubMed     Text format     Abstract available


  437. YU D, Zhang G, Huang X, Wu C, et al
    Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0126836.
    PubMed     Text format     Abstract available


  438. SINN DH, Cho JY, Gwak GY, Paik YH, et al
    Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread.
    PLoS One. 2015;10:e0124434.
    PubMed     Text format     Abstract available


  439. NEUMANN K, Erben U, Kruse N, Wechsung K, et al
    Chemokine Transfer by Liver Sinusoidal Endothelial Cells Contributes to the Recruitment of CD4+ T Cells into the Murine Liver.
    PLoS One. 2015;10:e0123867.
    PubMed     Text format     Abstract available


  440. GUO W, Zhang W, Liu C, Song Y, et al
    Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.
    PLoS One. 2015;10:e0129064.
    PubMed     Text format     Abstract available


  441. LIU X, Chi X, Gong Q, Gao L, et al
    Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    PLoS One. 2015;10:e0127518.
    PubMed     Text format     Abstract available


  442. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.
    PLoS One. 2015;10:e0121754.
    PubMed     Text format     Abstract available


  443. HUANG Y, Deng H, Shan X, Gong X, et al
    Lower mutation frequency of BCP/precore regions in e antigen-negative chronic HBV-infected children instead of adults patients.
    PLoS One. 2015;10:e0120733.
    PubMed     Text format     Abstract available


  444. LIN CK, Hung CC, Peng CY, Chao E, et al
    Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis.
    PLoS One. 2015;10:e0123687.
    PubMed     Text format     Abstract available


  445. YIN J, Wen J, Hang D, Han J, et al
    Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers-Hepatocellular Carcinoma and Cervical Cancer.
    PLoS One. 2015;10:e0132352.
    PubMed     Text format     Abstract available


  446. THAKARAR K, Morgan JR, Gaeta JM, Hohl C, et al
    Predictors of Frequent Emergency Room Visits among a Homeless Population.
    PLoS One. 2015;10:e0124552.
    PubMed     Text format     Abstract available


  447. OCHIENG C, Ahenda P, Vittor AY, Nyoka R, et al
    Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007.
    PLoS One. 2015;10:e0132645.
    PubMed     Text format     Abstract available


  448. HEIDRICH B, Cordes HJ, Klinker H, Moller B, et al
    Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.
    PLoS One. 2015;10:e0128069.
    PubMed     Text format     Abstract available


  449. GU L, Han Y, Li Y, Zhu T, et al
    Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
    PLoS One. 2015;10:e0134539.
    PubMed     Text format     Abstract available


  450. SCOTT N, McBryde E, Kirwan A, Stoove M, et al
    Modelling the Impact of Condom Distribution on the Incidence and Prevalence of Sexually Transmitted Infections in an Adult Male Prison System.
    PLoS One. 2015;10:e0144869.
    PubMed     Text format     Abstract available


    January 2014
  451. QU F, Zheng SJ, Liu S, Wu CS, et al
    Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure.
    PLoS One. 2014;9:e104988.
    PubMed     Text format     Abstract available


  452. KANAPATHIPILLAI R, McManus H, Kamarulzaman A, Lim PL, et al
    The Significance of HIV 'Blips' in Resource-Limited Settings: Is It the Same? Analysis of the Treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD).
    PLoS One. 2014;9:e86122.
    PubMed     Text format     Abstract available


  453. BANERJEE P, Mondal RK, Nandi M, Ghosh S, et al
    A rare HBV subgenotype d4 with unique genomic signatures identified in north-eastern India -an emerging clinical challenge?
    PLoS One. 2014;9:e109425.
    PubMed     Text format     Abstract available


  454. PEPIN J, Abou Chakra CN, Pepin E, Nault V, et al
    Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010.
    PLoS One. 2014;9:e99677.
    PubMed     Text format     Abstract available


  455. HUANG X, Tan H, Li X, Zhou S, et al
    Maternal chronic HBV infection would not increase the risk of pregnancy-induced hypertension - results from pregnancy cohort in liuyang rural china.
    PLoS One. 2014;9:e114248.
    PubMed     Text format     Abstract available


  456. ABDEL-MOHSEN M, Deng X, Danesh A, Liegler T, et al
    Role of MicroRNA Modulation in the Interferon-alpha/Ribavirin Suppression of HIV-1 In Vivo.
    PLoS One. 2014;9:e109220.
    PubMed     Text format     Abstract available


  457. BORGES AH, O'Connor JL, Phillips AN, Baker JV, et al
    Factors Associated with D-Dimer Levels in HIV-Infected Individuals.
    PLoS One. 2014;9:e90978.
    PubMed     Text format     Abstract available


  458. KATO N, Sejima H, Ueda Y, Mori K, et al
    Genetic characterization of hepatitis C virus in long-term RNA replication using li23 cell culture systems.
    PLoS One. 2014;9:e91156.
    PubMed     Text format     Abstract available


  459. HWANG KK, Trama AM, Kozink DM, Chen X, et al
    IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria.
    PLoS One. 2014;9:e90725.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: